\- Patient observed with metastatic breast cancer from the outset or metastatic fall from previously treated breast cancer with change of therapeutic line at the time of inclusion.
For participants with non-metastatic invasive breast cancer:
\- Patient observed with non-metastatic infiltrative breast cancer who had not received any treatment at the time of inclusion (naïve to any treatment)
For healthy volunteers:
Participant free of any cancer at the time of inclusion, confirmed using a mammogram whose results must be satisfactory, done at the latest two years before inclusion
Participant with no history of cancer
You may not be if
For all participants:
Male
Age less than 18 years old
Refusal to participate or withdrawal of consent
Pregnant and/or breastfeeding women
Discovery of a cancerous pathology (other than breast cancer for patients) during participant follow-up.
For healthy volunteers:
History of cancer
Detection of CTC (positive profile) during screening
Clareo Health | Evaluation of Circulating Tumor Cells (CTC) Relevance in Breast Cancer Follow-up Using the ScreenCell Device
